Kiromic BioPharma KRBP Stock
Kiromic BioPharma Price Chart
Kiromic BioPharma KRBP Financial and Trading Overview
| Kiromic BioPharma stock price | 3.2 USD |
| Previous Close | 3.46 USD |
| Open | 3.43 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1300 |
| Day's Range | 3.38 - 3.67 USD |
| 52 Week Range | 2.59 - 22.8 USD |
| Volume | 87.08K USD |
| Avg. Volume | 343.55K USD |
| Market Cap | 3.4M USD |
| Beta (5Y Monthly) | 0.17647 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KRBP Valuation Measures
| Enterprise Value | 13.31M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.2387097 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.503 |
Trading Information
Kiromic BioPharma Stock Price History
| Beta (5Y Monthly) | 0.17647 |
| 52-Week Change | -71.15% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 22.8 USD |
| 52 Week Low | 2.59 USD |
| 50-Day Moving Average | 3.78 USD |
| 200-Day Moving Average | 6.39 USD |
KRBP Share Statistics
| Avg. Volume (3 month) | 343.55K USD |
| Avg. Daily Volume (10-Days) | 131.91K USD |
| Shares Outstanding | 979.24K |
| Float | 648.29K |
| Short Ratio | 0.05 |
| % Held by Insiders | 4.07% |
| % Held by Institutions | 10.80% |
| Shares Short | 34.03K |
| Short % of Float | 5.33% |
| Short % of Shares Outstanding | 3.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -91.43% |
| Return on Equity (ttm) | -549.34% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -26480300 USD |
| Net Income Avi to Common (ttm) | -33008200 USD |
| Diluted EPS (ttm) | -66.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.05M USD |
| Total Cash Per Share (mrq) | 2.1 USD |
| Total Debt (mrq) | 11.97M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.177 |
| Book Value Per Share (mrq) | -8.313 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20294800 USD |
| Levered Free Cash Flow (ttm) | -11256913 USD |
Profile of Kiromic BioPharma
| Country | United States |
| State | TX |
| City | Houston |
| Address | 7707 Fannin Street |
| ZIP | 77054 |
| Phone | 832-968-4888 |
| Website | https://www.kiromic.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 31 |
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company develops ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.
Q&A For Kiromic BioPharma Stock
What is a current KRBP stock price?
Kiromic BioPharma KRBP stock price today per share is 3.2 USD.
How to purchase Kiromic BioPharma stock?
You can buy KRBP shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kiromic BioPharma?
The stock symbol or ticker of Kiromic BioPharma is KRBP.
Which industry does the Kiromic BioPharma company belong to?
The Kiromic BioPharma industry is Biotechnology.
How many shares does Kiromic BioPharma have in circulation?
The max supply of Kiromic BioPharma shares is 1.54M.
What is Kiromic BioPharma Price to Earnings Ratio (PE Ratio)?
Kiromic BioPharma PE Ratio is now.
What was Kiromic BioPharma earnings per share over the trailing 12 months (TTM)?
Kiromic BioPharma EPS is -7.42 USD over the trailing 12 months.
Which sector does the Kiromic BioPharma company belong to?
The Kiromic BioPharma sector is Healthcare.
Kiromic BioPharma KRBP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17019.88 USD — |
+0.59
|
5.94B USD — | 16917.51 USD — | 17032.66 USD — | — - | 5.94B USD — |
| NASDAQ HealthCare IXHC | 978.74 USD — |
-1.03
|
— — | 973.64 USD — | 990.74 USD — | — - | — — |
- {{ link.label }} {{link}}